Loading…

Homology modeling, molecular docking and MD simulation studies to investigate role of cysteine protease from Xanthomonas campestris in degradation of A? peptide

Cysteine protease is known to degrade amyloid beta peptide which is a causative agent of Alzheimer's disease. This cleavage mechanism has not been studied in detail at the atomic level. Hence, a three-dimensional structure of cysteine protease fromXanthomonas campestriswas constructed by homolo...

Full description

Saved in:
Bibliographic Details
Published in:Computers in biology and medicine 2013-12, Vol.43 (12), p.2063
Main Authors: Dhanavade, Maruti J, Jalkute, Chidambar B, Barage, Sagar H, Sonawane, Kailas D
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cysteine protease is known to degrade amyloid beta peptide which is a causative agent of Alzheimer's disease. This cleavage mechanism has not been studied in detail at the atomic level. Hence, a three-dimensional structure of cysteine protease fromXanthomonas campestriswas constructed by homology modeling using Geno3D, SWISS-MODEL, and MODELLER 9v7. All the predicted models were analyzed by PROCHECK and PROSA. Three-dimensional model of cysteine protease built by MODELLER 9v7 shows similarity with human cathepsin B crystal structure. This model was then used further for docking and simulation studies. The molecular docking study revealed that Cys17, His87, and Gln88 residues of cysteine protease form an active site pocket similar to human cathepsin B. Then the docked complex was refined by molecular dynamic simulation to confirm its stable behavior over the entire simulation period. The molecular docking and MD simulation studies showed that the sulfhydryl hydrogen atom of Cys17 of cysteine protease interacts with carboxylic oxygen of Lys16 of A? peptide indicating the cleavage site. Thus, the cysteine protease model fromX. campestrishaving similarity with human cathepsin B crystal structure may be used as an alternate approach to cleave A? peptide a causative agent of Alzheimer's disease.
ISSN:0010-4825
1879-0534
DOI:10.1016/j.compbiomed.2013.09.021